Arch Pharmalabs Announces Partnership With Orochem Technologies to Supply API for U.S. Innovator`s Late-Stage Clinical Development Program

Introduction of Simulated Moving Bed (SMB) Technology Enables Arch Pharmalabs to
Carve Niche in Pharmaceutical Development and Manufacturing
MADRID--(Business Wire)--
Arch Pharmalabs, Ltd., a leading provider of small molecule process R&D and full
life-cycle custom synthesis and manufacturing services, announced today it has
entered into a strategic partnership with Orochem Technologies, Inc., to
manufacture a U.S. innovator`s active pharmaceutical ingredient (API) in
late-stage clinical development using Simulated Moving Bed (SMB) technology.
Orochem Technologies manufactures SMB equipment and stationary chromatography
phases for Bioanalytical, Solid Phase Extraction, Flash and Preparative
applications. Financial terms were not disclosed.

The collaboration between Orochem Technologies and Arch Pharmalabs marks the
first time that plant-scale SMB has been used to manufacture an API in India.

"We are proud to synergize our world-class API development and manufacturing
capabilities with SMB technology to work on a U.S. innovator`s molecule in
India," said Ajit Kamath, CMD, Arch Pharmalabs. "Using our flexible SMB
capabilities, we can rapidly and cost-effectively tackle separation and
purification challenges during scale-up, and provide a reliable API or drug
intermediate supply chain throughout the product lifecycle. Our collaboration
with Orochem Technologies further strengthens our position as an
innovation-driven company and a trusted development and manufacturing partner
for global pharmaceutical companies."

"By partnering with Arch Pharmalabs, we are better able to bring Orochem`s novel
products and expertise to help pharmaceutical companies achieve higher
efficiencies in manufacturing processes requiring separation or purification,"
said Asha Oroskar, president and CEO, Orochem Technologies. "This collaboration
will significantly benefit our customers by offering dependable and
cost-effective solutions during API production."

About Simulated Moving Bed Technology

Simulated moving bed (SMB) chromatography is a continuous purification technique
that has higher throughput and requires up to 90 percent less solvent than
regular batch chromatography. Compared with other large-scale separation
technologies, SMB can provide high yield and high purity in a relatively short
time, and can reduce time to market while being eco-friendly.

About Orochem Technologies, Inc.

Orochem Technologies provides products and services that support academic,
government research institutions, pharmaceutical and biotech companies with
specialized chromatography stationary phases and sample preparation products
such as DNA and RNA purification kits, protein purification plates and other
materials to enable bioanalysis and oligonucleotide synthesis and purification.
The Company is a leading developer of customized individual and high throughput
sample preparation tools that span liquid handling, parallel synthesis,
purification and processing.

www.orochem.com

About Arch Pharmalabs Limited

With 2008-09 revenues of USD 200 million, 2,400 employees and 11 manufacturing
facilities (including cGMP, US FDA- and EDQM-approved sites) backed by two
state-of-the-art Process Technology centres, Arch Pharmalabs is a top-tier,
India-based pure-play provider of API development and manufacturing services to
the global pharmaceutical industry. In addition to SMB, Arch Pharmalabs`
manufacturing capabilities include bio-catalysis, high-potency manufacturing,
cryogenics, phosgenation, organometallics, diketene and other specialized
chemistry. The Company offers process R&D, custom synthesis and manufacture of
intermediates and APIs for pre-clinical, clinical and post-approval requirements
that are supported by comprehensive analytical and regulatory services. Arch
Pharmalabs also offers a wide range of merchant APIs backed by DMFs and other
suitable documentation. Arch was the recipient of the 2006 CNBC-ICICI Emerging
India award as the No.1 Medium Sized Company in the Pharmaceuticals & Chemicals
category.

www.archpharmalabs.com

Fleishman-Hillard
Barry Sudbeck, +1-415-318-4261

Copyright Business Wire 2009